These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 18398091)

  • 1. Doctors seek to prevent breast cancer recurrence by lowering insulin levels.
    Hede K
    J Natl Cancer Inst; 2008 Apr; 100(8):530-2. PubMed ID: 18398091
    [No Abstract]   [Full Text] [Related]  

  • 2. The antidiabetic drug metformin: a pharmaceutical AMPK activator to overcome breast cancer resistance to HER2 inhibitors while decreasing risk of cardiomyopathy.
    Vazquez-Martin A; Oliveras-Ferraros C; del Barco S; Martin-Castillo B; Menendez JA
    Ann Oncol; 2009 Mar; 20(3):592-5. PubMed ID: 19153119
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer.
    Guppy A; Jamal-Hanjani M; Pickering L
    Future Oncol; 2011 Jun; 7(6):727-36. PubMed ID: 21675836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin in cancer therapy: a new perspective for an old antidiabetic drug?
    Ben Sahra I; Le Marchand-Brustel Y; Tanti JF; Bost F
    Mol Cancer Ther; 2010 May; 9(5):1092-9. PubMed ID: 20442309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does use of metformin protect against cancer in Type 2 diabetes mellitus?
    Bo S; Benso A; Durazzo M; Ghigo E
    J Endocrinol Invest; 2012 Feb; 35(2):231-5. PubMed ID: 22490993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-lowering effects of metformin in women with early breast cancer.
    Goodwin PJ; Pritchard KI; Ennis M; Clemons M; Graham M; Fantus IG
    Clin Breast Cancer; 2008 Dec; 8(6):501-5. PubMed ID: 19073504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metformin, an antidiabetic molecule with anti-cancer properties].
    Beck E; Scheen AJ
    Rev Med Liege; 2013 Sep; 68(9):444-9. PubMed ID: 24180199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial.
    Hadad S; Iwamoto T; Jordan L; Purdie C; Bray S; Baker L; Jellema G; Deharo S; Hardie DG; Pusztai L; Moulder-Thompson S; Dewar JA; Thompson AM
    Breast Cancer Res Treat; 2011 Aug; 128(3):783-94. PubMed ID: 21655990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin: a therapeutic opportunity in breast cancer.
    Gonzalez-Angulo AM; Meric-Bernstam F
    Clin Cancer Res; 2010 Mar; 16(6):1695-700. PubMed ID: 20215559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifestyle changes to reduce the risk of breast cancer.
    Hairon N
    Nurs Times; 2007 Oct 9-15; 103(41):23-4. PubMed ID: 17985726
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of different doses of metformin on serum testosterone and insulin in non-diabetic women with breast cancer: a randomized study.
    Campagnoli C; Pasanisi P; Abbà C; Ambroggio S; Biglia N; Brucato T; Colombero R; Danese S; Donadio M; Venturelli E; Zito G; Berrino F
    Clin Breast Cancer; 2012 Jun; 12(3):175-82. PubMed ID: 22607767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and insulin resistance in breast cancer--chemoprevention strategies with a focus on metformin.
    Goodwin PJ; Stambolic V
    Breast; 2011 Oct; 20 Suppl 3():S31-5. PubMed ID: 22015290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin in the adjuvant breast cancer setting: a novel therapeutic target for lifestyle and pharmacologic interventions?
    Goodwin PJ
    J Clin Oncol; 2008 Feb; 26(6):833-4. PubMed ID: 18281653
    [No Abstract]   [Full Text] [Related]  

  • 14. Gerosuppressant metformin: less is more.
    Menendez JA; Cufí S; Oliveras-Ferraros C; Vellon L; Joven J; Vazquez-Martin A
    Aging (Albany NY); 2011 Apr; 3(4):348-62. PubMed ID: 21483040
    [No Abstract]   [Full Text] [Related]  

  • 15. Illuminating the diabetes-cancer link.
    Brower V
    J Natl Cancer Inst; 2012 Jul; 104(14):1048-50. PubMed ID: 22781433
    [No Abstract]   [Full Text] [Related]  

  • 16. Metformin and incident breast cancer among diabetic women: a population-based case-control study in Denmark.
    Bosco JL; Antonsen S; Sørensen HT; Pedersen L; Lash TL
    Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):101-11. PubMed ID: 21119073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin and cancer.
    Rizos CV; Elisaf MS
    Eur J Pharmacol; 2013 Apr; 705(1-3):96-108. PubMed ID: 23499688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells.
    Zakikhani M; Dowling R; Fantus IG; Sonenberg N; Pollak M
    Cancer Res; 2006 Nov; 66(21):10269-73. PubMed ID: 17062558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer research. Cancer prevention with a diabetes pill?
    Taubes G
    Science; 2012 Jan; 335(6064):29. PubMed ID: 22223788
    [No Abstract]   [Full Text] [Related]  

  • 20. Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial.
    Bonanni B; Puntoni M; Cazzaniga M; Pruneri G; Serrano D; Guerrieri-Gonzaga A; Gennari A; Trabacca MS; Galimberti V; Veronesi P; Johansson H; Aristarco V; Bassi F; Luini A; Lazzeroni M; Varricchio C; Viale G; Bruzzi P; Decensi A
    J Clin Oncol; 2012 Jul; 30(21):2593-600. PubMed ID: 22564993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.